Premium Cancer Screening

Through precise instrument measurement of height, weight, waist circumference and blood pressure; calculate BMI to scientifically assess whether weight is standard, body fat distribution status, blood pressure normality and obesity risk; provides important data for related clinical departments.

Through physical examination of skin integrity, superficial lymph node enlargement, thyroid size/texture, breast condition, spinal and limb joint mobility, and male external genitalia; digital rectal exam for preliminary assessment of rectal status; systematically detect signs of common surgical diseases or preliminarily exclude common surgical diseases.

Through inspection, palpation, auscultation and other physical examination methods, assess the basic condition of the heart, lungs, abdomen and other organs, peripheral vascular pulsation status, whether lower limbs are oedematous, and whether neurological superficial reflexes are normal; systematically detect signs of common diseases or preliminarily exclude common diseases.

Assess eye appearance and visual acuity; slit-lamp examination of the eye surface and conjunctiva including lens, vitreous, cornea and conjunctiva; fundoscopy of the posterior eye including retina, optic nerve, optic disc and retinal central vessels for abnormalities.

Check for colour vision disorders such as red-green colour blindness.

Assess risk of glaucoma and other intraocular pressure abnormalities by measuring intraocular pressure.

Routine examination of ears, nose, pharynx and tonsils; preliminary screening for related common diseases.

Through routine blood testing, check white blood cells, red blood cells, haemoglobin, platelets and other indicators to reflect the body's condition, such as anaemia, infection, haematological diseases, physical/chemical factor injuries, etc.

Detects red blood cell sedimentation rate; assists in screening for inflammation, infection, autoimmune diseases, tumours, etc. (ESR may increase during tumour progression).

Mainly reflects changes in blood fluidity, coagulability and blood viscosity; applicable to risk assessment of cardiovascular and cerebrovascular diseases.

A hydrolase secreted by the pancreas; indirectly indicates the presence of pancreatic infectious diseases or space-occupying lesions.

Evaluate whether glucose metabolism is normal under fasting conditions; assess whether diabetic patients' fasting blood glucose control has reached the target. Fasting blood glucose is a commonly used and important indicator for evaluating glucose metabolism disorders.

HbA1c concentration effectively reflects average blood glucose over the past 8-12 weeks; used for diabetes screening and evaluation of blood glucose control.

Provides a comprehensive understanding of liver function status; indicates hepatobiliary diseases: acute infectious hepatitis, toxic hepatitis, fatty liver, cholangitis, cholecystitis, drug-induced hepatitis, alcoholic hepatitis and jaundice.

Used to diagnose renal function abnormalities, gout, hyperuricaemia, etc. The urinary microalbumin/creatinine ratio is important for early screening and diagnosis of early renal damage from various causes; applicable to diabetic nephropathy, hypertensive patients, cardiovascular and renal high-risk populations, and early renal disease screening in healthy populations.

A simple and accurate method for screening urinary system diseases such as urinary tract infection, tumours and stones, and for assessing renal function; also used to assist in checking other systemic diseases such as diabetes, nephritis, etc.

An indicator for monitoring and evaluating renal function status; inflammation (generally upper urinary tract infection), renal failure, nephritis and renal tumours may cause abnormalities.

Reflects the body's lipid metabolism status; helps assess cardiovascular and cerebrovascular disease risk. sdLDL-C is significantly correlated with coronary artery spasm, angina pectoris, ACS and the degree of coronary stenosis. When AI>=4 the value is abnormal - the higher the value, the more severe the arteriosclerosis and the greater the cardiovascular/cerebrovascular risk.

A sensitive indicator of tissue damage and a biomarker of cardiovascular inflammatory lesions. Plays an important role in diagnosing and predicting coronary heart disease, stroke and peripheral vascular thrombosis.

Closely related to atherosclerotic cardiovascular/cerebrovascular disease; an independent risk factor for cardiovascular and cerebrovascular diseases.

A specific indicator of myocardial injury; high sensitivity and specificity for diagnosing myocardial infarction.

PGI, PGII and PGI/PGII ratio determination can be used for initial screening of gastric cancer, gastric ulcer and atrophic gastritis.

A positive C13 urea breath test indicates Helicobacter pylori infection, which is closely associated with gastric inflammation, peptic ulcers and gastric cancer. This method is painless, rapid and accurate.

Applicable for screening occult gastrointestinal bleeding diseases.

Used to diagnose hyperthyroidism and hypothyroidism, and for post-operative treatment monitoring of thyroid tumours; more sensitive than the thyroid function 3-item panel for diagnosing hyperthyroidism.

An important serological indicator for diagnosing rheumatoid arthritis; also seen in certain infectious diseases such as tuberculosis and infective endocarditis.

A serological test indicator for rheumatic fever; has important reference value in diagnosing rheumatic arthritis.

Has certain reference significance for screening rheumatic diseases, immune complex-related diseases and autoimmune-related diseases.

Has important clinical significance for the diagnosis, treatment monitoring and prognosis evaluation of primary liver cancer; also supports auxiliary assessment of gastric, pancreatic and testicular cancers, hepatitis and liver cirrhosis.

A broad-spectrum tumour marker with important clinical significance for colorectal and pancreatic cancer screening, treatment monitoring and prognosis evaluation; may also be elevated in gastric, breast and lung cancers.

Important for pancreatic, biliary and gastrointestinal cancer screening, treatment monitoring and prognosis evaluation; may also be elevated in acute pancreatitis, cholangitis, cholelithiasis, acute hepatitis and liver cirrhosis.

In prostatitis and prostatic hyperplasia, t-PSA is mildly elevated; when both t-PSA and f-PSA are elevated with a decreased f-PSA/t-PSA ratio, prostate cancer may be indicated.

In prostatitis and prostatic hyperplasia, t-PSA is mildly elevated; when both t-PSA and f-PSA are elevated with a decreased f-PSA/t-PSA ratio, prostate cancer may be indicated.

Important for early diagnosis and prognosis evaluation of small-cell lung cancer and neuroblastoma.

Assists in initial screening of squamous cell-origin tumours; an auxiliary indicator for lung squamous cell carcinoma and oesophageal cancer diagnosis, disease monitoring and prognosis.

Important for early diagnosis, treatment monitoring and prognosis of non-small-cell lung cancer.

Used for early auxiliary diagnosis of nasopharyngeal carcinoma.

Colour ultrasound imaging of the liver, gallbladder, pancreas and spleen to detect any morphological changes or space-occupying lesions (tumours, stones, inflammation, etc.).

Colour ultrasound imaging of bilateral kidneys to detect any morphological changes or space-occupying lesions (tumours, stones, inflammation, etc.).

Colour ultrasound of the thyroid to detect any morphological changes or space-occupying lesions (enlargement, nodules, adenomas, tumours, etc.).

Colour ultrasound to detect atherosclerosis and carotid artery conditions.

Colour ultrasound dynamically displays cardiac chamber structure, cardiac pulsation and valvular blood flow; an important tool for diagnosing various heart diseases.

Colour ultrasound to detect prostatic masses and other lesions.

Head MRI directly displays cranial nerves and detects early neural lesions; no skull artefacts and high grey-white matter signal contrast make it significantly superior to CT.

Low-dose spiral CT (LDCT) optimises tube current, voltage and pitch to reduce radiation dose to about 20% of conventional chest CT. LDCT helps detect early lung cancer - pulmonary tumours of approximately 0.5 cm can be clearly imaged, especially peripheral lung cancer, with a detection rate about 10 times that of chest X-ray. The lower radiation dose effectively reduces the risk of iatrogenic radiation-induced malignancy.

Uses low-frequency pulsed waves to objectively evaluate haemodynamic changes in the basal arteries, internal carotid arteries and external carotid arteries caused by intracranial arterial changes (stenosis, occlusion, vascular malformations, etc.).

Through measurement of four-limb blood pressure and related calculations, early determination of arteriosclerosis, lower-limb arterial stenosis/occlusion and varicose veins; also assists in checking peripheral vascular thrombosis.

Through ultrasound transmission rate, detects bone density of the lower-limb ankle; evaluates bone mass and possible osteoporosis.

Through synchronous recording and analysis of the electrical activity curve of each cardiac cycle at specific body surface locations; provides an important basis for cardiac disease diagnosis, treatment evaluation and prognosis assessment.